These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years]. Takahashi Y; Ochi H; Yanai A; Yamashita H; Itoh K; Mimori A Nihon Naika Gakkai Zasshi; 2010 Jan; 99(1):130-2. PubMed ID: 20196484 [No Abstract] [Full Text] [Related]
7. Tocilizumab for multirefractory adult-onset Still's disease. De Bandt M; Saint-Marcoux B Ann Rheum Dis; 2009 Jan; 68(1):153-4. PubMed ID: 19088261 [No Abstract] [Full Text] [Related]
8. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission. Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710 [TBL] [Abstract][Full Text] [Related]
9. Successful slow tocilizumab desensitization in a patient with adult onset Still disease. Erdogan T; Yasar Bilge NS; Kasifoglu T Biologicals; 2018 Sep; 55():17-18. PubMed ID: 30017556 [No Abstract] [Full Text] [Related]
10. [Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease]. Sekkach Y; Elqatni M; Khattabi AE; Fatihi J; Hammi S; Badaoui M; Elomri N; Mekouar F; Amezyane T; Abouzahir A; Ghafir D Presse Med; 2011; 40(7-8):e333-7. PubMed ID: 21550202 [TBL] [Abstract][Full Text] [Related]
11. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186 [TBL] [Abstract][Full Text] [Related]
12. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years. Nakahara H; Mima T; Yoshio-Hoshino N; Matsushita M; Hashimoto J; Nishimoto N Mod Rheumatol; 2009; 19(1):69-72. PubMed ID: 18762861 [TBL] [Abstract][Full Text] [Related]
13. IgA nephropathy in adult-onset Still's disease after tocilizumab treatment: a case report. Kang JH Int Urol Nephrol; 2022 May; 54(5):1167-1168. PubMed ID: 34269969 [No Abstract] [Full Text] [Related]
14. Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab. Yamada H; Kaneko Y; Tamai H; Takeuchi T Rheumatology (Oxford); 2020 Feb; 59(2):440-442. PubMed ID: 31504968 [No Abstract] [Full Text] [Related]
15. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum. Saito J; Yakuwa N; Kaneko K; Takai C; Goto M; Nakajima K; Yamatani A; Murashima A Rheumatology (Oxford); 2019 Aug; 58(8):1505-1507. PubMed ID: 30945743 [No Abstract] [Full Text] [Related]
16. [Adult onset Still's disease with small vessel vasculitis]. Hoff P; Hoyer BF; Schneider U; Kneitz C; Burmester GR; Buttgereit F Z Rheumatol; 2015 Aug; 74(6):540-2. PubMed ID: 26231832 [TBL] [Abstract][Full Text] [Related]
17. Tocilizumab in adult-onset Still's disease: the Israeli experience. Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still's Disease. Vandemergel X; Vandergheynst F Acta Medica (Hradec Kralove); 2016; 59(1):22-5. PubMed ID: 27131353 [TBL] [Abstract][Full Text] [Related]